http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#Head
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#assertion
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#provenance
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#pubinfo
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#assertion
http://purl.obolibrary.org/obo/MONDO_0002046
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/MONDO_0002046
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/DRUGBANK:DB00657
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#association
http://www.w3.org/2000/01/rdf-schema#label
The nicotinic-acetylcholine receptor (nAchR)- antagonist mecamylanine has been found to reduce the stimulus produced by ethanol in human lab studies. The nAchR-antagonist varenicline has also displayed positive effect in reducing alcohol consumption in multiple clinical trials. In this 12- week double-blind trial, participants (n 1⁄4 126) were randomized to either mecamylamine (10 mg daily) or placebo. No medication effect was found for reducing heavy drinking days (HDD) or alcohol craving. Smoking status had no effect on the results. The authors suggest that broad-spectrum nAchR-antagonists may not be beneficial in treat- ing AUD
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#association
https://w3id.org/biolink/vocab/publications
https://pubmed.ncbi.nlm.nih.gov/30973369
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#association
https://w3id.org/biolink/vocab/relation
https://w3id.org/um/neurodkg/OffLabelIndication
https://identifiers.org/DRUGBANK:DB00657
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#provenance
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#assertion
http://www.w3.org/ns/prov#generatedAtTime
2021-08-24T17:09:05.80667
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#pubinfo
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#sig
http://purl.org/nanopub/x/hasSignature
LWyPq6TCC7JRCYWpQrKGFxo+G4kWqOnqMpbnqgNlAgJwkcKSXNDhbnesKo2LYlf00KPsejPghpfPiYVKeoR5YPQRrRLmAubvQExSRkPRfMPIokScBAgClXgg9HIz8tX3iI8vEGFu1OpzF3/7retE0Igg5lA0rJV6tcayXLIPof0=
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok
http://purl.org/dc/terms/created
2021-08-25T18:14:02.481+02:00
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-7641-6446
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok
http://purl.org/nanopub/x/supersedes
http://purl.org/np/RAHTMDPT6XyaNv0R67W6y6nJwpAEHJF9fWpEuYXfoUtgo
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok
http://www.w3.org/ns/prov#generatedAtTime
2021-08-24T17:09:05.80667
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-7641-6446
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RAcm8OurwUk15WOgBM9wySo-T3a5h6as4K8YR5MBrrxUc
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RA2vCBXZf-icEcVRGhulJXugTGxpsV5yVr9yqCI1bQh4A
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAjpBMlw3owYhJUBo3DtsuDlXsNAJ8cnGeWAutDVjuAuI
http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY